Fairey William
Insider CIK 1727275 · CCXI Chief Operating Officer · KALV Director · ALRN Director · MYOK See Remarks · MIRM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-06-15 | 2026-06-17 | 1,980 | — | $0 | 1,980 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-06-15 | 2026-06-17 | 3,772 | — | $0 | 3,772 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 10,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 30,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 17,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2025-10-01 | 2025-10-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RNTX Rein Therapeutics, Inc. | A Award deriv | 2025-07-23 | 2025-07-23 | 17,500 | — | $0 | 17,500 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-06-11 | 2025-06-13 | 3,203 | $48.42 | $155.1K | 2,500 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-05-29 | 2025-06-02 | 5,703 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-05-29 | 2025-06-02 | 3,977 | — | $0 | 3,977 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-05-29 | 2025-06-02 | 6,268 | — | $0 | 6,268 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-05-29 | 2025-06-02 | 5,703 | — | $0 | 5,703 | SEC↗ |
| ALRN Aileron Therapeutics, Inc. | A Award deriv | 2024-12-02 | 2024-12-06 | 35,000 | — | $0 | 35,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2024-10-03 | 2024-10-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALRN Aileron Therapeutics, Inc. | A Award deriv | 2024-08-20 | 2024-08-22 | 2,725 | — | $0 | 2,725 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 8,779 | — | $0 | 8,779 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 5,703 | — | $0 | 5,703 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2024-04-18 | 2024-04-22 | 17,000 | — | $0 | 17,000 | SEC↗ |
| ALRN AILERON THERAPEUTICS INC | A Award deriv | 2023-10-31 | 2023-11-02 | 5,450 | — | $0 | 5,450 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2023-06-12 | 2023-06-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2022-06-02 | 2022-06-06 | 12,750 | — | $0 | 12,750 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2021-08-19 | 2021-08-20 | 34,000 | — | $0 | 34,000 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 69,500 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 39,022 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | U Tender | 2020-11-17 | 2020-11-19 | 42,199 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2020-02-14 | 2020-02-19 | 12,598 | — | $0 | 12,598 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2020-02-14 | 2020-02-19 | 39,022 | — | $0 | 39,022 | SEC↗ |
| MYOK MyoKardia Inc | M Exercise deriv | 2020-02-01 | 2020-02-03 | 8,125 | — | $0 | 24,375 | SEC↗ |
| MYOK MyoKardia Inc | S Sale | 2020-02-01 | 2020-02-03 | 2,899 | $68.04 | $197.2K | 5,226 | SEC↗ |
| MYOK MyoKardia Inc | M Exercise | 2020-02-01 | 2020-02-03 | 8,125 | — | $0 | 8,125 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2019-02-01 | 2019-02-05 | 69,500 | — | $0 | 69,500 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2019-02-01 | 2019-02-05 | 32,500 | — | $0 | 32,500 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2018-01-03 | 2018-01-05 | 575,000 | — | $0 | 575,000 | SEC↗ |